- Division of Translational and Clinical Sciences – DTCS
- Review Branch:
- Cancer Diagnosis, Prevention & Therapeutics – CDPT
- Study Section:
- Cellular Immunotherapy of Cancer – CIC
Before joining CSR, Dr. Shahana Majid was an associate professor at the University of California, San Francisco. The main focus of Dr. Majid’s research was to understand the genetic, epigenetic, molecular signaling pathways and non-coding RNAs that drive initiation, progression and metastasis of urological cancers. In addition, she worked to develop novel molecular biomarkers for early detection and risk assessment of urological cancers. Through collaborations, Dr. Majid also investigated molecular mechanisms underlying melanoma, cholangiocarcinoma and breast cancer. Dr. Majid has published 94 research articles in peer reviewed journals including PNAS, JNCI, CDD, cancer research and clinical cancer research.